Growth Hormone

Biogenerics debate rumbles on

Biogenerics debate rumbles on

Representatives of the pharmaceutical and biotechnology industries
presented strong opposition to the concept of biogenerics at a
recent meeting convened by the US Food and Drug Administration. As
expected, their argument centred...

Lilly invests heavily in UK

Lilly invests heavily in UK

US pharmaceutical major Eli Lilly has earmarked a hefty £220
million (€304 million) investment over the next four years in its
UK facilities, representing the largest investment by the firm in
any European country.


Follow us


View more


Featured Suppliers